Xlife Sciences AG
ISIN: CH0461929603 | Ticker: XLS | LEI: 984500AH590BE88BB517
Country: Switzerland
We bring selected projects in the four areas of technology platforms, biotechnologies/therapies, medical technology (health technology), and artificial intelligence in the life science sector and digital health to the next stage of development.We lead these projects from the very beginning after an invention has been made and typically commercialize them after two to three years by, e.g., a trade sale, by entering into a joint venture with an industrial partner or by outlicensing patents.
For the identification, selection and development of our projects, we benefit from our growing network with universities, clinical centers and research institutions.Typically, we incorporate a separate Portfolio company for each project. Currently, we have a portfolio of 22 Portfolio Companies, in which we hold at least a minority stake. More information about these Portfolio Companies can be found here.
Worldwide
Headcount11
HeadquartersTalacker 35, 8001 Zurich – Switzerland
| Date | Trading entity / Person | Association | Trade type | Volume |
|---|---|---|---|---|
| 15.06.22 | None | Executive member | Buy | CHF 6,000.00 |
| 15.06.22 | None | Executive member | Buy | CHF 3,000.00 |
| 14.06.22 | None | Executive member | Buy | CHF 15,500.00 |
| 10.06.22 | None | Executive member | Buy | CHF 6,728.90 |
| 07.06.22 | None | Executive member | Buy | CHF 34,800.00 |
| 03.06.22 | None | Executive member | Buy | CHF 3,540.00 |
| 24.05.22 | None | Executive member | Buy | CHF 3,400.00 |
| 17.05.22 | None | Executive member | Buy | CHF 10,794.20 |
| 13.05.22 | None | Executive member | Buy | CHF 3,690.00 |
| 10.05.22 | None | Executive member | Buy | CHF 1,935.00 |
CH0461929603
LEI984500AH590BE88BB517
SectorPharmaceuticals, Biotechnology & Life Sciences
IndustryKeep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.